Understanding How the New U.S. Patent Laws Affect Business Strategy for Emerging Pharmaceutical, Biotechnology, and Medical Device Companies

With the “America Invents Act” and new U.S. patent laws now in effect or being implemented over the next year, emerging pharmaceutical, biotechnology, and medical device companies are asking what are the implications of the changes and how do we adapt?

During the seminar, attendees will gain insight on building a business and patent portfolio strategy that responds to the new first-to-file patent system. Additionally, attendees will learn about the potential advantages under the new patent laws with regard to maintaining certain information as trade secrets.

Who Should Attend

Pharmaceutical, biotechnology, and medical device business executives; university researchers; and technology transfer officers.

Speakers 

Mark J. Feldstein, Ph.D. 

Time

5:00 – 5:30 p.m. Registration
5:30 – 7:00 p.m. Program
7:00 – 8:00 p.m. Reception

Where

North Carolina Biotechnology Center
Dogwood Room
15 T.W. Alexander Drive
Research Triangle Park, NC 27709

Registration

Register by Friday, May 11. There is no charge to attend the program. Space is limited, so please register early.